免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

MDx-Chex 靈敏測試用於乳癌早期診斷

K 號:K231221 · 2023-07-27

申請人Streck
決定日期2023-07-27
產品代碼PMN
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

MDx-Chex for BC-GP is the device name listed in this FDA 510(k) record. The listed applicant is Streck. It received FDA 510(k) clearance on 2023-07-27 under 510(k) number K231221. The device is classified under product code PMN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the MDx-Chex for BC-GP?

MDx-Chex for BC-GP is a medical device that received FDA 510(k) clearance on 2023-07-27. The listed applicant is Streck. The 510(k) number is K231221.

When did MDx-Chex for BC-GP receive FDA 510(k) clearance?

MDx-Chex for BC-GP received FDA 510(k) clearance on 2023-07-27, under 510(k) number K231221.

Who is the listed applicant for MDx-Chex for BC-GP?

The FDA 510(k) record lists Streck as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MDx-Chex for BC-GP?

The FDA product code for MDx-Chex for BC-GP is PMN.

其他以 Streck 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 8 項裝置 →

相關器械(代碼:PMN)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑